Grants Awarded
Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.
New awards will be posted as they are issued.
| Year |
Award Type |
Project # | RFA # | PI/Project Leader | Institution | Title | Status |
|---|---|---|---|---|---|---|---|
| 2002 | R43 | CA096059 | PAR-01-105 | LOGE, GARY | SPECTRUMEDIX CORPORATION | AN AUTOMATED 2D-CAPILLARY ELECTROPHORESIS SYSTEM | Complete |
| 1999 | R43 | CA081951 | PAR-98-066 | XANTHOPOULOS, KLEANTHIS G | AURORA BIOSCIENCES CORPORATION | ID OF NOVEL BREAST CANCER AGENTS BY FUNCTIONAL GENOMICS | Complete |
| 2001 | R43 | CA084679 | PAR-98-066 | PERLIN, MARK W | CYBERGENETICS CORPORATION | AUTOMATED MULTIPLEX GENETIC ANALYSIS TECHNOLOGY | Complete |
| 2004 | R43 | CA108005 | PAR-01-105 | HEILIG, JOSEPH S | SOMALOGIC, INC. | APTAMER DEVELOPMENT FOR CANCER DIAGNOSIS AND MANAGEMENT | Complete |
| 2003 | R43 | CA099111 | PAR-01-105 | SHEN, LI | SUPERARRAY BIOSCIENCE CORPORATION | ID-TAG PROTEIN PROFILING ARRAY FOR THE MOLECULAR CHARACT | Complete |
| 2000 | R43 | CA084679 | PAR-98-066 | PERLIN, MARK W | CYBERGENETICS CORPORATION | AUTOMATED MULTIPLEX GENETIC ANALYSIS TECHNOLOGY | Complete |
| 2002 | R43 | CA096065 | PAR-01-105 | GAU, VINCENT JEN-JR | GENEFLUIDICS, INC. | RAPID MOLECULAR DETECTION OF PML/RARALPHA | Complete |
| 1999 | R43 | CA081952 | PAR-98-066 | CHEE, MARK S. | ILLUMINA, INC. | GENE EXPRESSION ANALYSIS ON RANDOMLY ORDERED DNA ARRAYS | Complete |
| 2003 | R43 | CA101271 | PAR-01-105 | DIATCHENKO, LUDA | ATTAGENE, INC. | PROFILING OF SIGNAL TRANSDUCTION PATHWAYS IN CANCER | Complete |
| 2009 | R43 | CA137737 | RFA-CA-08-011 | ZWICK, MICHAEL G | ANDROBIOSYS, INC. | PRIMARY XENOGRAFTS OF HUMAN TISSUE AS SURROGATES OF CANCER IN SITU | Complete |
| 2000 | R43 | CA084686 | PAR-98-066 | BOGEN, STEVEN A | CYTOLOGIX CORPORATION | INSTRUMENTATION FOR IN SITU ANALYSIS TUMORS | Complete |
| 2002 | R43 | CA096069 | PAR-01-105 | YANG, XING | GENEOHM SCIENCES, INC. | MULTIPLEXED DNA-MEDIATED ELECTOCHEMICAL SENSORS | Complete |
| 2001 | R44 | CA081965 | PAR-99-101 | BITTER, GRANT A. | BITTECH, INC. | DNA MISMATCH REPAIR FUNCTIONAL GENETIC TESTS | Complete |
| 2004 | R44 | CA105539 | PAR-01-105 | BATTRELL, CHARLES FRED | MICRONICS, INC. | MICROFLUIDIC POINT-OF-CARE CANCER CELL ANALYZER | Complete |
| 2001 | R44 | CA083396 | PAR-99-101 | GITE, SADANAND | AMBERGEN, INC | NOVEL TECHNOLOGY FOR THE ANALYSIS OF GENE EXPRESSION | Complete |
| 2004 | R44 | CA107988 | PAR-01-105 | BALGLEY, BRIAN M | CALIBRANT BIOSYSTEMS, INC. | INTEGRATED TOP-DOWN/BOTTOM-UP COMPREHENSIVE PROTEOMICS | Complete |
| 2009 | R44 | CA140047 | RFA-CA-08-011 | CHEN, WEN-TIEN | VITATEX, INC. | CANCER PROGENIYOR CELL MARKERS | Complete |
| 2001 | R44 | CA083598 | PAR-99-101 | RAO, CHANDRA | IMMUNICON CORPORATION | ANALYSIS OF CIRCULATING CANCER CELLS EARLY IN DISEASE | Complete |
| 2004 | R44 | CA099126 | PAR-01-105 | ZEBALA, JOHN A | SYNTRIX BIOSYSTEMS, INC. | ARTIFICIAL ANTIBODY MIMETICS | Complete |
| 2009 | R44 | CA115041 | RFA-CA-08-013 | ZOU, NIANXIANG | BIO-QUICK CORPORATION | DEVELOPMENT OF ULTRASOUND-FACILITATED FORMALIN-FIXED AND PARAFFIN-EMBEDDED TISSUE | Complete |
| 2001 | R44 | CA088684 | PAR-99-101 | LEVENSON, RICHARD M. | CAMBRIDGE RESEARCH AND INSTRUMENTATION | SIMPLE, LOW-COST, ULTRA-RAPID SPECTRAL IMAGING PLATFORM | Complete |
| 2004 | R44 | CA099333 | PAR-01-105 | ZEBALA, JOHN A | SYNTRIX BIOSYSTEMS, INC. | INSTRUMENTATION FOR HIGH-RESOLUTION ANALYSIS OF CANCER | Complete |
| 2003 | R44 | CA084804 | PAR-01-104 | GOLOVLEV, VAL V | SCI-TEC, INC. | MAGNETICALLY READABLE MICROARRAY | Complete |
| 2009 | R44 | CA130026 | RFA-CA-07-010 | LEVENSON, RICHARD M. | CAMBRIDGE RESEARCH AND INSTRUMENTATION | CELLULARLY RESOLVED MOLECULAR PATHWAY ASSESSMENT IN BIOPSIES VIA SPECTRAL IMAGING | Complete |
| 2020 | R44 | CA236097 | PAR-18-303 | LIM, MARK | AMBERGEN, INC | Highly Multiplexed Nanoscale Mass Spectrometric Imaging Of Cancer Tissues | Active |
| 2004 | R44 | CA105539 | PAR-01-105 | BATTRELL, CHARLES FRED | MICRONICS, INC. | MICROFLUIDIC POINT-OF-CARE CANCER CELL ANALYZER | Complete |
| 2003 | R44 | CA099117 | PAR-01-105 | NEDELKOV, DOBRIN | INTRINSIC BIOPROBES, INC. | AFFINITY-BASED MASS SPECTROMETRY PROTEIN ASSAYS | Complete |
| 2009 | R44 | CA134258 | RFA-CA-07-039 | GUO, BAOCHUAN | GLC BIOTECHNOLOGY, INC. | MMPA: A NOVEL MULTIPLEXING METHYLATION ANALYSIS TECHNOLOGY | Complete |
| 2007 | R44 | CA128858 | RFA-CA-07-008 | DOLINGER, DAVID LEE | IQUUM, INC. | RAPID POINT-OF-CARE ASSAY FOR DETECTING HIGH RISK HUMAN PAPILLOMAVIRUS | Complete |
| 2014 | R44 | CA161965 | PAR-13-327 | LIM, MARK | AMBERGEN, INC | GLOBAL PROTEOMIC SCREENING BY MALDI SPECTROMETRIC IMAGING OF PROTEIN-BEAD ARRAYS | Complete |
| 2003 | R44 | CA099126 | PAR-01-105 | ZEBALA, JOHN A | SYNTRIX BIOSYSTEMS, INC. | ARTIFICIAL ANTIBODY MIMETICS | Complete |
| 2009 | R44 | CA134310 | RFA-CA-07-041 | LEE, BRIAN W | IMMUNOCHEMISTRY TECHNOLOGIES, LLC | NEW FLUORESCENT CASPASE DETECTION PROBES TO LABEL APOPTOTIC TUMOR CELLS IN VIVO | Complete |
| 2007 | R44 | CA130026 | RFA-CA-07-010 | LEVENSON, RICHARD M. | CAMBRIDGE RESEARCH AND INSTRUMENTATION | CELLULARLY RESOLVED MOLECULAR PATHWAY ASSESSMENT IN BIOPSIES VIA SPECTRAL IMAGING | Complete |
| 2010 | R44 | CA133987 | RFA-CA-08-011 | DUFFY, DAVID C | TWIN LIGHTS BIOSCIENCE, INC. | SINGLE MOLECULE FIBER ARRAYS FOR THE DETECTION OF LOW ABUNDANCE PROTEINS | Complete |
| 2003 | R44 | CA099333 | PAR-01-105 | ZEBALA, JOHN A | SYNTRIX BIOSYSTEMS, INC. | INSTRUMENTATION FOR HIGH-RESOLUTION ANALYSIS OF CANCER | Complete |
| 2009 | R44 | CA118785 | RFA-CA-06-006 | SCHWARZBACH, ANNA | ASURAGEN, INC. | MIRNA PROFILING IN FIXED CANCER SAMPLES | Complete |
| 2010 | R44 | CA140047 | RFA-CA-08-011 | CHEN, WEN-TIEN | VITATEX, INC. | CANCER PROGENIYOR CELL MARKERS | Complete |
| 2017 | R44 | CA188154 | PAR-13-327 | PREMSRIRUT, PREM KHOVABUTR | MIRIMUS, INC. | Next generation CRISPR/Cas9-RNAi mouse models for accelerated drug discovery research | Complete |
| 2003 | R44 | CA083390 | PAR-01-105 | WIKTOR, PETER J. | ENGINEERING ARTS | PIEZOELECTRIC PIPETTING TECHNOLOGY FOR DNA ANALYSIS | Complete |
| 2002 | R44 | CA094400 | PAR-99-101 | GAO, JUN | CALIBRANT BIOSYSTEMS, INC. | ELECTRONIC PROTEIN TRANSFER FOR PROTEOME ANALYSIS | Complete |
| 2002 | R44 | CA094419 | PAR-99-101 | ZEBALA, JOHN A | SYNTRIX BIOSYSTEMS, INC. | LIGHT-UP PNA ARRAYS | Complete |
| 2003 | R44 | CA094400 | PAR-99-101 | GAO, JUN | CALIBRANT BIOSYSTEMS, INC. | ELECTRONIC PROTEIN TRANSFER FOR PROTEOME ANALYSIS | Complete |
| 2013 | R44 | CA133987 | RFA-CA-08-011 | DUFFY, DAVID C | QUANTERIX CORPORATION | SINGLE MOLECULE FIBER ARRAYS FOR THE DETECTION OF LOW ABUNDANCE PROTEINS | Complete |
| 2000 | R44 | CA088684 | PAR-99-101 | LEVENSON, RICHARD M. | CAMBRIDGE RESEARCH AND INSTRUMENTATION | SIMPLE, LOW-COST, ULTRA-RAPID SPECTRAL IMAGING PLATFORM | Complete |
| 2002 | R44 | CA081835 | PAR-01-105 | DREES, BETH E | ECHELON BIOSCIENCES, INC. | PHOSPHOINOSITIDE 3-KINASE ASSAYS IN CANCER DIAGNOSIS | Complete |
| 2003 | R44 | CA099117 | PAR-01-105 | NEDELKOV, DOBRIN | INTRINSIC BIOPROBES, INC. | AFFINITY-BASED MASS SPECTROMETRY PROTEIN ASSAYS | Complete |
| 2000 | R44 | CA081954 | PAR-98-066 | LIFSHITZ, NADIA | BIOPHOTONICS CORPORATION | HIGH THROUGHPUT, HIGH RESOLUTION DNA SEQUENCING | Complete |
| 2002 | R44 | CA088396 | PAR-01-105 | MOEN, PHILLIP T | ONE CELL SYSTEMS, INC | DISCRETE ASSAY FOR INTEGRATED HPV DNA IN CERVICAL CELLS | Complete |
| 2020 | R44 | CA250672 | PAR-18-303 | WINTERS, IAN PAUL | D2G ONCOLOGY, INC. | Relating Drugs To Genotypes To Transform Precision Cancer Therapeutics With Tuba-seq - A Novel, Highly Scalable And Quantitative Preclinical Experimental Oncology Platform | Active |
| 2000 | R44 | CA082038 | PAR-98-066 | ANDERSON, N LEIGH | LARGE SCALE BIOLOGY CORPORATION | PROTEOMIC TECHNOLOGIES FOR CANCER RESEARCH | Complete |